Medical Supply Chain Resiliency Act (S. 998/HR 2213). Reauthorization of the Pandemic and All-Hazards Preparedness Act (PAHPA) either as standalone legislation or inclusion in a larger package such as S.891, the Bipartisan Health Care Act.
2025 · 3rd Quarter (July 1 - Sep 30)
HEALTH INDUSTRY DISTRIBUTORS ASSOCIATION
Filed by HEALTH INDUSTRY DISTRIBUTORS ASSOCIATION.
Open official filingSource-reported fields
Filing overview
- Type
- 3rd Quarter - Report
- Posted
- Oct 20, 2025
- Income
- Not reported
- Expenses
- $30,000.00
- Registrant
- HEALTH INDUSTRY DISTRIBUTORS ASSOCIATION
- Filing UUID
- bef9bb19-1d21-421a-95db-fa7183f75e52
- Termination date
- Not reported
Expense method: A
Literal source text
Lobbying issues and bill citations
S.257, the Promoting Resilient Supply Chains Act of 2025. Implementation of HR 6140, enacted as Section 3522 of Public Law 118-159:Facilitating Access to Swiftly Transport Goods during a Publicly Announced State of Emergency Situation (FAST PASS) Act.
Legislative and executive branch action with respect to tariffs and tariff exclusions on medical products: including IEEPA reciprocal tariffs, IEEPA border/fentanyl tariffs on China, Mexico and Canada, tariff investigations pursuant to Sec 301 and Sec 232 on medical products. Medical Supply Chain Resiliency Act (S. 998/HR 2213)
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.